Comments
Lilly drug slows Alzheimer's in some, fails main goals
25.08.2012. | NEW YORK/CHICAGO (Reuters) - Eli Lilly and Co said its experimental Alzheimer's drug showed signs of slowing mental decline in patients with a mild form of the disease, even though it failed to meet the main goals of two large clinical trials, suggesting the treatment could be salvaged....
